Aldose reductase activity and glucose-related opacities in incubated lenses from dogs and cats

American Journal of Veterinary Research

Volumn 63, Issue 11, 2002, Pages 1591-1597

  Richter, Marianne ^a   Guscetti, Franco ^a   Spiess, Bernhard ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; GLUCOSE;

AGE; AGED; ARTICLE; CAT; CATARACT; CATARACTOGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DOG; ENZYME ACTIVITY; HISTOPATHOLOGY; INCUBATION TIME; NONHUMAN; SPECTROPHOTOMETRY;

CANIS FAMILIARIS; FELIDAE; FELIS CATUS;

EID: 0036847199     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.1591     Document Type: Article

References (63)

1. Marmor M, Willeberg P Glickman LT, et al. Epizootiologic patterns of diabetes mellitus in dogs. Am J Vet Res 1982;43:465-470.
2. Panciera DL, Thomas CB, Eicker SW, et al. Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986). J Am Vet Med Assoc 1990; 197:1504-1508.
3. Crenshaw KL, Peterson ME. Pretreatment clinical and laboratory evaluation of cats with diabetes mellitus: 104 cases (1992-1994). J Am Vet Med Assoc 1996;209:943-949.
4. Nelson RW. Diabetes mellitus In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 4th ed. Philadelphia: WB Saunders Co, 1995;1510-1537
5. Salgado D, Reusch C, Spiess B. Diabetic cataracts: different incidence between dogs and cats. Schweiz Arch Tierheilkd 2000;142:349-353.
6. Basher AW, Roberts SM. Ocular manifestations of diabetes mellitus: diabetic cataracts in dogs. Vet Clin North Am Small Anim Pract 1995;25:661-676.
7. Peiffer RL, Gelatt KN. Cataracts in the cat. Feline Pract 1974:34-38.
8. Olwen DJ. Spontaneous diabetes mellitus in the cat. Vet Rec 1960:630.
9. Bron AJ, Sparrow J, Brown NA, et al. The lens in diabetes. Eye 1993;7:260-275.
10. Creighton MO, Stewart-DeHaan PJ, Ross WM, et al. Modelling cortical cataractogenesis: 1. In vitro effects of glucose, sorbitol and fructose on intact rat lenses in medium 199. Can J Ophthalmol 1980;15:183-188.
11. Jedziniak JA, Chylack LT Jr, Cheng HM, et al. The sorbitol pathway in the human lens: aldose reductase and polyol dehydrogenase. Invest Ophthalmol Vis Sci 1981;20:314-326.
12. Varma SD, Kinoshita JH. The absence of cataracts in mice with congenital hyperglycemia. Exp Eye Res 1974;19:577-582.
13. Lee AY, Chung SK, Chung SS. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Natl Acad Sci U S A 1995;92:2780-2784.
14. Chylack LT Jr, Kinoshita JFL A biochemical evaluation of a cataract induced in a high-glucose medium. Invest Ophthalmol 1969;8:401-412.
15. Chylack LT, Jr, Cheng HM. Sugar metabolism in the crystalline lens. Surv Ophthalmol 1978;23:26-34.
16. Lou MF, Kinoshita JH. Control of lens glycolysis. Biochim Biophys Acta 1967;141:547-559.
17. Cohen-Melamed E, Nyska A, Pollack A, et al. Aldose reductase (EC 1.1.1.21) activity and reduced-glutathione content in lenses of diabetic sand rats (Psammomys obesus) fed with acarbose. Br Nutr 1995;74:607-615.
18. Muirhead Rp Hothersall JS. The effect of phenazine methosulphate on intermediary pathways of glucose metabolism in the lens at different glycaemic levels. Exp Eye Res 1995;61:619-627.
19. Kubo E, Maekawa K, Tanimoto T, et al. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (CLETE) rat. Exp Eye Res 2001;73:375-381.
20. Kinoshita JH, Barber GW, Merola LO, et al. Changes in the levels of free amino acids and myo-mositol in the galactose-exposed lens. Invest Ophthalmol 1969;8:625-632.
21. Kuriyama H, Sasaki K, Fukuda M. Studies on diabetic cataract in rats induced by streptozotocin. II. Biochemical examinations of rat lenses in relation to cataract stages. Ophthalmic Res 1983;15:191-197.
22. Carper D, Kaneko M, Stark H, et al. Increase in aldose reductase mRNA in dog lens epithelial cells under hypertonic conditions. Exp Eye Res 1990;50:743-749.
23. Lee AY, Chung SS. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J 1999; 13:23-30.
24. Ling GV, Lowenstine LJ, Pulley LT, et al. Diabetes mellitus in dogs: a review of initial evaluation, immediate and long-term management, and outcome. J Am Vet Med Assoc 1977;170:521-530.
25. Piper HM, Spahr R, Krutzfeldt A, et al. Changes in the energy metabolism of cultured lens epithelial cells in comparison with the fresh lens. Exp Eye Res 1990;51:131-138.
26. Korte I. Lens culture systems In: Hockwin O, Green K, Rubin LF, eds. Manual of oculotoxicity testing of drugs. Stuttgart, Germany: Gustav Fischer, 1992;403-409.
27. Kamiya T, Zigler JS Jr. Long-term maintenance of monkey lenses in organ culture: a potential model system for the study of human cataractogenesis. Exp Eye Res 1996;63:425-431.
28. Cheng HM, Gonzalez RG, Barnett PA, et al. Sorbitol/fructose metabolism in the lens. Exp Eye Res 1985;40:223-229.
29. Dickerson JE Jr, Lou MF, Gracy RW. The culture of rat lenses in high sugar media: effect on mixed disulfide levels. Curr Eye Res 1995;14:109-118.
30. Sato S, Kador PF. NADPH-dependent reductases of the dog lens. Exp Eye Res 1990;50:629-634.
31. Sato S, Takahashi Y, Wyman M, et al. Progression of sugar cataract in the dog. Invest Ophthalmol Vis Sci 1991;32:1925-1931.
32. Salgado D, Forrer RS, Spiess BM. Activities of NADPH-dependent reductases and sorbitol dehydrogenase in canine and feline lenses. Am J Vet Res 2000;61:1322-1324.
33. Neeley WE. Simple automated determination of serum or plasma glucose by a hexokinase-glucose-6 -phosphate dehydrogenase method. Clin Chem 1972;18:509-515.
34. Okuda J, Kawamura M, Didelot S. Anomeric preference in Uptake of D-glucose and Of D-galactose by rat lenses. Curr Eye Res 1987;6:1223-1226.
35. Gum GG. Physiology of the eye. In: Gelatt KN, ed. Veterinary ophthalmology. 2nd ed. Philadelphia: Lea & Febiger, 1991;124-161.
36. Cheng HM, Hirose K, Xiong H, et al. Polyol pathway activity in streptozotocin-diabetic rat lens. Exp Eye Res 1989;49:87-92.
37. Akagi Y, Kador PF. Kinoshita JH Immunohistochemical localization for aldose reductase in diabetic lenses. Invest Ophthalmol Vis Sci 1987;28:163-167.
38. Crabbe MJ, Bron AJ, Peckar CO, et al. NADPH-oxidising activity in lens and erythrocytes in diabetic and nondiabetic patients with cataract. Br J Ophthalmol 1983;67:696-699.
39. Ghahary A, Chakrabarti S, Sima AA, et al. Effect of insulin and statil on aldose reductase expression in diabetic rats. Diabetes 1991;40:1391-1396.
40. Srivastava SK, Ansari NH, Hair GA, et al. Activation of human erythrocyte, brain, aorta, muscle, and ocular tissue aldose reductase. Metabolism 1986;35:114-118.
41. Hamada Y, Kito R, Raskin P Increased erythrocyte aldose reductase activity in type 1 diabetic patients. Diabetic Med 1991;8:226-231.
42. Hamada Y, Hammon K, Raskin P. No correlation between glycemic control and an increase in erythrocyte aldose reductase activity in type I and type II diabetic patients. J Diabetes Complications 1992;6:111-115.
43. Nishimura C, Saito T, Ito T, et al. High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients. Diabetologia 1994;37:328-330.
44. Bekhor I, Shi ST, Unakar NJ. Management of aldose reductase mRNA abundance in rat lens undergoing reversal of galactose induced cataracts. A model for gene response to changes in the environment. Mol Cell Biochem 1990;95:55-60.
45. Bekhor I, Shi S, Carper D, et al. Relative abundance of aldose reductase mRNA in rat lens undergoing development of osmotic cataracts. Curr Eye Res 1989;8:1299-1308.
46. Wu RR, Lyons PA, Wang A, et al. Effects of galactose feeding on aldose reductase gene expression. J Clin Invest 1993;92:155-159.
47. Qin C, Tumminia SJ, Russell P et al. investigations into the loss of glutathione from lenses in organ culture. Curr Eye Res 1996;15:719-725.
48. Cappiello M, Voltarelli M, Giannessi M, et al. Glutathione dependent modification of bovine lens aldose reductase. Exp Eye Res 1994;58:491-501.
49. Lackner PA, Rodriguez L, Sato S, et al. Age-dependent lens changes in galactose-fed dogs. Exp Eye Res 1997;64:431-436.
50. Varma SD, Mizuno A, Kinoshita JH. Diabetic cataracts and flavonoids. Science 1977;195:205-206.
51. Jacob TJ, Duncan G. Glucose-induced membrane permeability changes in the lens. Exp Eye Res 1982;34:445-453.
52. Old SE, Carper DA, Hohman TC. Na, K-ATPase response to osmotic stress in primary dog lens epithelial cells. Invest ophthalmol Vis Sci 1995;36:88-94.
53. Patterson JW. Effect of incubation medium electrolyte concentration on lens volume. Ophthalmic Res 1980;12:97-110.
54. Patterson JW The effect of ouabain on volume regulation in the rat lens. Invest Ophthalmol Vis Sci 1981;20:40-46.
55. Obrosova IG, Stevens MJ. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. Invest Ophthalmol Vis Sci 1999;40:680-688.
56. Malone JI, Lowitt S, Cook WR. Nonosmotic diabetic cataracts. Pediatr Res 1990;27:293-296.
57. Yokoyama T, Lin LR, Chakrapani B, et al. Hypertonic stress increases NaK ATPase, taurme, and myoinositol in human lens and retinal pigment epithelial cultures. Invest Ophthalmol Vis Sci 1993;34:2512-2517.
58. Cheng HM, Xiong J, Tanaka G, et al. Analysis of concurrent glucose consumption by the hexose monophosphate shunt, glycolysis, and the polyol pathway in the crystalline lens. Exp Eye Res 1991;53:363-366.
59. Obrosova I, Faller A, Burgan J, et al. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor. Curr Eye Res 1997; 16:34-43.
60. Obrosova I, Cao X, Greene DA, et al. Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect Of DL-alpha-lipoic acid. Diabetologia 1998;41: 1442-1450.
61. Blakytny R, Harding JJ. Glyeation (non-enzymic glycosylation) inactivates glutathione reductase. Biochem J 1992;288:303-307.
62. Hunt JV, Wolff SP. Oxidative glycation and free radical production: a causal mechanism of diabetic complications. Free Radic Res Commun 1991;12-13:115-123.
63. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 1991;10:339-352.